Relentless Innovation to Avail Breakthrough Therapies to a Global Community
XBiotech is perhaps the most dynamic Biopharmaceutical company anywhere: A cancer therapy program with two unique pivotal Phase III clinical studies involving an agent that makes patients feel better, while undermining the tumor's ability to grow, spread and do harm; Multiple indications in Phase II clinical development; A discovery pipeline of therapeutic antibodies that are safer and better tolerated than ever before; And novel manufacturing technology to reduce cost and complexity of drug development.
  • About Us

    XBiotech is building on a foundation of remarkable new therapies, innovative approaches to commercialization and a commitment to realizing treatments for unmet medical needs worldwide.

    The Company is a leading developer of biological therapies—including a pipeline of True Human™ antibodies and proven blockbuster biosimilars.

    read more

Clinical Trials

View all current trials

Company news

view all company news